Lincoln Pharmaceuticals Ltd launches Vitamin C + Zinc Tablets

▴ Lincoln Pharmaceuticals Ltd launches Vitamin C + Zinc Tablets
Lincoln Pharmaceuticals Ltd launches Vitamin C + Zinc Tablets to boost immunity in the fight against COVID-19

With a commitment towards "Healthcare For All", Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has launched Chewable Vitamin C + Zinc Tablet for the markets in India. The tablet is an evidence-based bio-active for natural immunity in a combination with zinc that boosts antiviral activity and protection against COVID 19. Market size for Vitamin C and Zinc tablets is estimated at around Rs. 150 crores in India and growing at 15% per annum.

Mr. Ashish R. Patel, Whole-Time Director, Lincoln Pharmaceuticals Limited, said, "During this COVID 19 Pandemic, Immunity & immunity boosters are the only way to protect against the Virus. Vitamin-C & Zinc tablet have become necessity and important part of all human being in their day to day life. With this launch, we aim to fill the gaps in serving the healthcare requirement of the masses with our wide range of 600 plus formulations. As it is in the form of Chewable Tablet, Geriatric and pediatric patients and travelling patients who may not have ready access to water are most need of easy swallowing dosage forms like chewable tablets with a pleasant flavor. Company is committed to fight the COVID-19 pandemic and working closely with the governments and relevant stakeholders to ensure uninterrupted supply of medicines."

Lincoln Pharmaceuticals Limited is one of the leading companies in the pharmaceutical industry, engaged in the business of manufacturing of Tablets, Capsules, Dry Syrup, Liquid Vials, Injectables and Ointments etc. The Company develops and manufactures affordable and innovative medicines for healthier lives. The company is also building a strong portfolio in lifestyle and chronic segments especially in women healthcare and dermatology to complement our strong presence in the acute segment.

The Company has developed 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynecology, cardio & CNS, anti-bacterial, anti-diabetic, anti-malaria among others. The company has a strong presence in the domestic market with good strength of its own field force and also exports to more than 60 countries. The company has filled 25 plus patent applications and is awarded seven patents.

Lincoln Pharma has a state-of-the-art manufacturing facility unit at Khatraj in Ahmedabad, Gujarat, complying with stringent international quality and compliance norms and certified by EUGMP, WHO-GMP and ISO-9001: 2015. With the EU certification, the company will expand its business network to 90 plus countries. Company currently exports to 60 plus countries including East & West Africa, Central & Latin America and Southeast Asia and has got many product registrations in these countries and is also awarded with a number of global tenders.

Tags : #LincolnPharmaceuticals #VitaminCPlusZincTab #AshishRpatel #Ahmedabad #Pharmanewsupdate #Immunity #Covid-19

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Behind the success of every working woman, there are many working women: Neha Dhupia, Beauty Pageant, Model and Bollywood ActressDecember 11, 2023
Universal Health Care: India races against time; experts call for scaling up both Infrastructure and Delivery SystemDecember 11, 2023
China Doctors Remove Live Worms from Woman’s Eyes HealthCare December 11, 2023
Immunity Boosting Measures for Optimal Health during WinterDecember 11, 2023
How to Save Gaza’ Catastrophic For HealthCareDecember 11, 2023
Broccoli Important For Our Health December 11, 2023
Seminar on RERA: Concerns in Real Estate heldDecember 09, 2023
Commonwealth youth leaders want action, not just rhetoric at COP28December 09, 2023
South India’s biggest Gaushala, Satyam Shivam Sundaram Gau Nivas to conduct Annakut Celebrations on Sunday on the eve of its 23rd AnniversaryDecember 08, 2023
Center for Diagnostics and Telemedicine Introduces Groundbreaking Service – Preliminary Clinical and Technical Testing for Medical SoftwareDecember 08, 2023
FTCCI to hold a Seminar on RERA: Concerns in Real EstateDecember 08, 2023
Adoption of Public Health Strategies and Early Detection Key for Cancer Mitigation: ExpertsDecember 08, 2023
Are online spaces safe for women?December 08, 2023
Ayurveda is an ancient science for modern times: Dr T.S. Prasad, Ayush Integrated Wellness Center, NIMSDecember 07, 2023
Prescribing Equality: Tackling Gender Disparities in India's Healthcare LeadershipDecember 07, 2023
Digitalizing Health: Generative AI's Impact Amplified by AWS Cloud in IndiaDecember 07, 2023
Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023
Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023
Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy PartnershipDecember 06, 2023
Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023